#GeographicAtrophy (GA), an advanced form of age-related macular degeneration (AMD), affects approximately 8 million people globally. It is a leading cause of irreversible central vision loss, with limited treatment options. At Johnson & Johnson, we’re leveraging cutting-edge science to better understand GA disease and advance research to restore and preserve vision. #GAAwarenessWeek #JNJOphthalmology